The effect of statins on microalbuminuria, proteinuria, progression of kidney function, and all-cause mortality in patients with non-end stage chronic kidney disease: A meta-analysis

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Zhenhong ZhangGengxin Zhang

Abstract

Conclusive evidence regarding the effect of statins on non-end stage chronic kidney disease (CKD) has not been reported previously. This meta-analysis evaluated the association between statins and microalbuminuria, proteinuria, progression, and all-cause mortality in patients with non-end stage CKD. Databases (e.g., PubMed, Embase and the Cochrane Library) were searched for randomized controlled trials (RCTs) with data on statins, microalbuminuria, proteinuria, renal health endpoints, and all-cause mortality patients with non-end stage CKD to perform this meta-analysis. The mean difference (MD) of the urine albumin excretion ratios (UAER), 24-h urine protein excretion, and risk ratios (RR) of all-cause mortality and renal health endpoints were calculated, and the results are presented with 95% confidence intervals (CI). A total of 23 RCTs with 39,419 participants were selected. The analysis demonstrated that statins statistically reduced UAER to 26.73 μg/min [95%CI (-51.04, -2.43), Z=2.16, P<0.05], 24-h urine protein excretion to 682.68 mg [95%CI (-886.72, -478.63), Z=6.56, P<0.01] and decreased all-cause mortality [RR=0.78, 95%CI (0.72, 0.84), Z=6.08, P<0.01]. However, the analysis results did not indicate that statins reduced...Continue Reading

References

Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
Feb 1, 1996·Controlled Clinical Trials·A R JadadH J McQuay
Oct 6, 1997·BMJ : British Medical Journal·M EggerC Minder
May 1, 2002·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Tsukasa NakamuraHikaru Koide
Jul 10, 2002·Hypertension·Tsung-Ming LeeChang-Her Tsai
Mar 4, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Stefano BianchiVito M Campese
Sep 2, 2004·Journal of the American Society of Nephrology : JASN·Anja VerhulstMarc E De Broe
Sep 2, 2004·Journal of the American Society of Nephrology : JASN·Rajiv Agarwal
Oct 20, 2004·Circulation·Folkert W AsselbergsUNKNOWN Prevention of Renal and Vascular Endstage Disease Intervention Trial (PREVEND IT) Investigators
Oct 29, 2005·The American Journal of Cardiology·Anil VermaNeil F Gordon
Jun 10, 2006·Journal of the American Society of Nephrology : JASN·Sabrina SandhuMarcello Tonelli
Jul 19, 2006·Annals of Internal Medicine·Kevin DouglasJeffrey L Jackson
Mar 6, 2007·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Michel ChoncholJoAnn Lindenfeld
Nov 3, 2007·Mayo Clinic Proceedings·Rajiv Agarwal
Aug 5, 2008·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Mahboob RahmanUNKNOWN ALLHAT Collaborative Research Group
Feb 14, 2009·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Michael J KorenUNKNOWN ALLIANCE Investigators
Apr 9, 2009·Pharmacology & Therapeutics·Theodoros I Kassimatis, Panagiotis A Konstantinopoulos
May 9, 2009·Atherosclerosis·Haruo NakamuraUNKNOWN MEGA Study Group
Jun 23, 2009·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Helen M ColhounUNKNOWN CARDS Investigators
Apr 12, 2014·Clinical Journal of the American Society of Nephrology : CJASN·Melissa A CadnapaphornchaiRobert W Schrier
Jul 9, 2014·The American Journal of Cardiology·Qiang GengHong Chen

❮ Previous
Next ❯

Citations

Jul 26, 2019·Expert Opinion on Pharmacotherapy·Niki KatsikiMaciej Banach
Mar 13, 2020·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Bo LiYunhe Zhao
Nov 16, 2017·Oncotarget·Bo LiFengshuang An
Oct 5, 2019·F1000Research·Diego Francisco MárquezLuis Ruilope
Nov 6, 2018·Scientific Reports·Ping-Jen HuYuh-Feng Lin
Apr 16, 2020·International Journal of Molecular Sciences·Lucas Opazo-RíosJesús Egido
Jun 20, 2020·Critical Care : the Official Journal of the Critical Care Forum·Xianghong YangDechang Chen
Jul 18, 2020·Thrombosis and Haemostasis·Shanen JinXianghong Yang
Nov 10, 2020·Archives of Endocrinology and Metabolism·Roberta de Pádua BorgesMarcello Casaccia Bertoluci
Jul 31, 2021·American Journal of Preventive Cardiology·Harold E BaysPeter P Toth

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban
Ye-Fang ZhangHong-Bing Zeng
Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Marcin BarylskiLipid and Blood Pressure Meta-Analysis Collaboration Group
© 2022 Meta ULC. All rights reserved